|Dr. Qin Ning is a Professor in Hepatology and Clinical Immunology. She is the director of the State Key Laboratory for Zoonotic Diseases in China; the chair of institute & Department of Infectious Diseases in Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Dr. Ning’s clinical care activities include hepatology, clinical immunology, and infectious disease, with focus on viral hepatitis, and recently emerging SARS-CoV-2 infected COVID-19.
Dr. Ning Dr. Ning has published over 300 peer reviewed articles, including BMJ-British Medical Journal, Journal of Hepatology, Signal Transduction and Targeted Therapy, Lance Gastroentology and Hepatology, J Clinical Investigation, Hepatology International, J Immunol, etc. These works have been cited by SCI papers for more than 7000 times.
Dr. Ning is the Vice President, Chinese Society of Infectious Disease CMA; Global Council Member, International Association for the Study of Liver (IASL); Member for APASL ACLF Study Group and International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) Global Hepatitis Summit (GHS); Executive Committee Member for Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP)